Medicament for treating hyperplasia of mammary glands

Abstract

The invention relates to a medicine for treating lobular hyperplasia of galactophore, which aims at solving the technical problems that the prior medicine for treating lobular hyperplasia of galactophore fails to address both the symptoms and root causes. The medicine comprises the following compositions in weight portion: 5 to 30 portions of angelica, 10 to 60 portions of radices paeoniae alba, 10 to 30 portions of dandelion, 5 to 25 portions of bistortae, 5 to 35 portions of herba violae, 15 to 45 portions of spreading hedyotis herb, 15 to 45 portions of barbat skullcap and 0.6 to 5 portions of tamoxifen. The medicine contains compositions of traditional Chinese medicines and western medicines which are synergic to take effect; the compositions of traditional Chinese medicines soothe liver, invigorate spleen, nourish blood and regulate menstruation; and the compositions of western medicines can competitively obstruct an estrogen receptor, thereby completely removing pathogeny and address the disease both symptoms and root causes.

Description

technical field [0001] The invention relates to a medicine for treating mammary gland hyperplasia, in particular to a medicine for treating mammary gland lobular hyperplasia. Background technique [0002] Breast lobular hyperplasia is the most common non-tumor, non-inflammatory hyperplastic lesion, and is the most common breast disease in women, with a certain cancer rate. May occur at any age after puberty. The lesion is a pathological process dominated by dilatation, hyperplasia and cystic changes of gland lobules and mammary duct terminals. Its occurrence and development are related to ovarian endocrine dysfunction, mostly due to insufficient secretion of progesterone and relative or absolute excess of estrogen, resulting in disorder of breast tissue hyperplasia and involution during the menstrual cycle. The depression, loneliness and anxiety caused by bad mental stimulation are the "catalysts" of breast lobular hyperplasia, which are more common in 25-40 years old with...

AI Technical Summary

Problems solved by technology

Publication number CN 1557359A, the Chinese patent document titled "A Plaster for Treating Hyperplasia of Mammary Glands and Its Preparation Method" discloses a combination of pangolin, musk, bezoar, pearl, cinnabar, borax, frankincense, myrrh, saponin thorn, borneol The medicine made, but it selects famous and precious Chinese medicinal materials, and the treatment cost is relatively high; Publication No. CN 1857550A, the Chinese patent document titled "a pharmaceutical composition for treating breast lobular hyperplasia and its preparation method" discloses a Traditional Chinese medicine prescriptions made from raw materials such as Bupleurum, Angelica, Cyperi, Wang Buliuxing, Chishao, Qingpi, Tangerine Peel, Salvia, etc.